All In Biotech

Free tool

FAERS Monitor: Venlafaxine Besylate

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 215429 or its brand name (Venlafaxine Besylate, Venlafaxine Besylate). Reports on generic versions are filed under their own applications.

Reports

58,351

Serious

48,491

83% of reports

Hospitalization

21,481

Death reported

8,442

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective3,903
  • toxicity to various agents3,736
  • fatigue3,326
  • nausea3,255
  • off label use2,815
  • completed suicide2,791
  • drug interaction2,670
  • headache2,617
  • dizziness2,416
  • diarrhoea2,171
  • depression2,082
  • anxiety2,044
  • fall1,988
  • vomiting1,986
  • intentional overdose1,874

Reports by year received

View as table
YearReports
200477
200576
200613
20073
200831
2009236
2010656
2011985
20121,428
20131,551
20141,842
20152,808
20163,305
20173,771
20184,883
20195,378
20205,208
20214,467
20224,129
20234,709
20244,784
20254,549
20263,461

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,995,808 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
completed suicideSignal2,79112.512.028,524
intentional overdoseSignal1,87410.810.316,252
toxicity to various agentsSignal3,7368.17.923,071
drug interactionSignal2,6706.25.911,410
depressionSignal2,0823.33.23,378
anxietySignal2,0442.62.52,025
fallSignal1,9882.22.11,250
dizziness2,4161.71.7790
fatigue3,3261.51.5655
vomiting1,9861.51.5365
headache2,6171.51.5457
nausea3,2551.51.4532
diarrhoea2,1711.21.283
off label use2,8151.21.164
drug ineffective3,9031.11.018

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.